Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1646-1653

  Lazzarino, Mario ^a   Orlandi, E ^a   Paulli, M ^a   Strater J ^a   Klersy, C ^a   Gianelli, U ^a   Gargantini, L ^a   Rousset, M T ^a   Gambacorta, M ^a   Marra, E ^a   Lavabre Bertrand, T ^a   Magrini, U ^a   Manegold, C ^a   Bernasconi, C ^a   Moller P ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; STATISTICAL ANALYSIS; SUPERIOR CAVA VEIN SYNDROME; SURVIVAL RATE; TREATMENT PLANNING;

EID: 17344374497     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1646     Document Type: Article

References (33)

1. Miller JB, Variakojis D, Bitran JD, et al: Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction. Cancer 47:748-756, 1981
2. Levitt LJ, Aisenberg AC, Harris NL, et al: Primary non-Hodgkin's lymphoma of the mediastinum. Cancer 50:2486-2492, 1982
3. Trump DL, Mann RB: Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostic subset of patients with non-Hodgkin's lymphoma. Cancer 50: 277-282, 1982
4. Addis BJ, Isaacson PG: Large cell lymphoma of the mediastinum: A B cell tumour of probable thymic origin. Histopathology 10:379-390, 1986
5. Menestrina F, Chilosi M, Bonetti F, et al: Mediastinal large-cell lymphoma of the B type, with sclerosis: Histopathologic and immunohistochemical study of eight cases. Histopathology 10:589-600, 1986
6. Möller P, Lammler B, Eberlein-Gonska M, et al: Primary medi-astinal clear cell lymphoma of B-cell type. Virchow Arch (Pathol Anat) 409:79-92, 1986
7. Harris NL, Jaffe ES, Stein H, et al: A Revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
8. Jacobson JO, Aisenberg AC, Lamarre L, et al: Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 62:1893-1898, 1988
9. Haioun C, Gaulard P, Roudot-Thoraval F, et al: Mediastinal diffuse large-cell lymphoma with sclerosis: A condition with a poor prognosis. Am J Clin Oncol 12:425-429, 1989
10. Lamarre L, Jacobson JO, Aisenberg AC, et al: Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 13:730-739, 1989
11. Todeschini G, Ambrosetti A, Meneghini V, et al: Mediastinal large-B-cell lymphoma with sclerosis: A clinical study of 21 patients. J Clin Oncol 8:804-808, 1990
12. Lavabre-Bertrand T, Donadio D, Fegueux N, et al: A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer 69:2561-2566, 1992
13. Kirn D, Mauch P, Shaffer K, et al: Large-cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients. J Clin Oncol 11:1336-1343, 1993
14. Lazzarino M, Orlandi E, Paulli M, et al: Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 11:2306-2313, 1993
15. Rohatiner AZS, Whelan JS, Ganjoo RK, et al: Mediastinal large-cell lymphoma with sclerosis. Br J Cancer 69:601-604, 1994
16. Perrone T, Frizzera G, Rosai J: Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol 10:176-191, 1986
17. Möller P, Moldenhauer G, Momburg F, et al: Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood 69:1087-1095, 1987
18. Scarpa A, Bonetti F, Menestrina F, et al: Mediastinal large-cell lymphoma with sclerosis. Genotypic analysis establishes its B nature. Virchow Arch (Pathol Anat) 412:17-21, 1987
19. Al-Sharabati M, Chittal S, Duga-Neulat I, et al: Primary anterior mediastinal B-cell lymphoma. A clinicopathologic and immunohistochemical study of 16 cases. Cancer 67:2579-2587, 1991
20. Isaacson PG, Norton AJ, Addis BJ: The human thymus contains a novel population of B lymphocytes. Lancet 2:1488-1491, 1987
21. Hofmann WJ, Momburg F, Möller P: Thymic medullary cells expressing B lymphocyte antigens. Human Pathol 19:1280-1287, 1988
22. Davis RE, Dorfman RF, Warnke RA: Primary large-cell lymphoma of the thymus: A diffuse B-cell neoplasm presenting as primary mediastinal lymphoma. Human Pathol 21:1262-1268, 1990
23. Aisenberg AC: Primary large-cell lymphoma of the mediastinum. J Clin Oncol 11:2291-2294, 1993
24. Rodriguez J, Pugh WC, Romaguera JE, et al: Primary mediastinal large cell lymphoma. Hematol Oncol 12:175-184, 1994
25. Bertini M, Orsucci L, Vitolo U, et al: Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol 2:733-737, 1991
26. Falini B, Venturi S, Martelli M, et al: Mediastinal large B-cell lymphoma: Clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 89:780-789, 1995
27. Cazals-Hatem D, Lepage E, Brice P, et al: Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 20:877-888, 1996
28. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
29. Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984
30. Swan F, Velasquez WS, Tucker S, et al: A new serologic staging system for large-cell lymphomas based on initial β2-microglobulin and lactate dehydrogenase levels. J Clin Oncol 7:1518-1527, 1989
31. Lazzarino M, Orlandi E, Astori C, et al: A low serum β2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: Implications for serologic staging. Eur J Haematol 57:331-333, 1996 (letter)
32. Canellos GP: Residual mass in lymphoma may not be residual disease. J Clin Oncol 6:931-933, 1988
33. Kaplan WD, Jochelson MS, Herman TS, et al: Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 8:1966-1970, 1990